The UK Chancellor’s messaging at Davos recalled former Taoiseach Enda Kenny’s efforts to extol the recovery of the Irish ...

In a move to position itself as a Pan-African pharmaceutical leader, Neimeth International Pharmaceuticals is targeting the ...

AbbVie is a Dividend King that's quickly moving past reliance on Humira. Enbridge shouldn't be affected by potential Canadian ...

Recent health news includes Pfizer settling a lawsuit about a diversity fellowship, a New York doctor indicted for prescribing abortion pills in Louisiana, AstraZeneca canceling UK investment, ...

A private boarding school in rural western Massachusetts that opened in the 19th century is receiving a $50 million bequest ...

PLX READ THE FULL PLX RESEARCH REPORT Reasons To Own / A Compelling Idea for 2025 Protalix Biotherapeutics, Inc. (NYSE:PLX) ...

As the blizzard of announcements coming from the White House during Donald Trump's first weeks in office continues, Irish ...

The ad was graded as an “A” by the Kellogg students and place 9 th on AdMeter. It also made iSpot Tv’s list of the most likeable Super Bowl ads of 2025. It did not make Sprout Social’s list of the top ...

The year 2024 was marked by economic-financial and socio-political convulsions, which accentuated Romania's vulnerabilities ...

Water is the hidden ingredient in many products and production processes, but it is taking an increasingly central role as ...

H.C. Wainwright analysts increased their price target on Protalix BioTherapeutics (NYSE:PLX) stock to $15.00 from the previous $10.00 while continuing to recommend a Buy rating for the company. The ...